241 related articles for article (PubMed ID: 22296667)
21. Mutation of p53 Gene and Its Correlation with the Clinical Outcome in Dogs with Lymphoma.
Koshino A; Goto-Koshino Y; Setoguchi A; Ohno K; Tsujimoto H
J Vet Intern Med; 2016; 30(1):223-9. PubMed ID: 26678182
[TBL] [Abstract][Full Text] [Related]
22. Flow cytometric evaluation of ki67 for the determination of malignancy grade in canine lymphoma.
Poggi A; Miniscalco B; Morello E; Comazzi S; Gelain ME; Aresu L; Riondato F
Vet Comp Oncol; 2015 Dec; 13(4):475-80. PubMed ID: 24341365
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical and histochemical stains for differentiating canine cutaneous round cell tumors.
Fernandez NJ; West KH; Jackson ML; Kidney BA
Vet Pathol; 2005 Jul; 42(4):437-45. PubMed ID: 16006603
[TBL] [Abstract][Full Text] [Related]
24. Characterization of lymphocytes in canine gastrointestinal lymphoma.
Coyle KA; Steinberg H
Vet Pathol; 2004 Mar; 41(2):141-6. PubMed ID: 15017027
[TBL] [Abstract][Full Text] [Related]
25. Microvessel density in normal lymph nodes and lymphomas of dogs and their correlation with vascular endothelial growth factor expression.
Wolfesberger B; Tonar Z; Witter K; Guija de Arespacohaga A; Skalicky M; Walter I; Thalhammer JG; Egger GF
Res Vet Sci; 2008 Aug; 85(1):56-61. PubMed ID: 17888471
[TBL] [Abstract][Full Text] [Related]
26. Indolent cutaneous T-cell lymphoma presenting as cutaneous lymphocytosis in dogs.
Affolter VK; Gross TL; Moore PF
Vet Dermatol; 2009 Oct; 20(5-6):577-85. PubMed ID: 20178497
[TBL] [Abstract][Full Text] [Related]
27. Canine Splenic Nodular Lymphoid Lesions: Immunophenotyping, Proliferative Activity, and Clonality Assessment.
Sabattini S; Lopparelli RM; Rigillo A; Giantin M; Renzi A; Matteo C; Capitani O; Dacasto M; Mengoli M; Bettini G
Vet Pathol; 2018 Sep; 55(5):645-653. PubMed ID: 29807508
[TBL] [Abstract][Full Text] [Related]
28. The diagnostic assessment of canine lymphoma: implications for treatment.
Bienzle D; Vernau W
Clin Lab Med; 2011 Mar; 31(1):21-39. PubMed ID: 21295720
[TBL] [Abstract][Full Text] [Related]
29. Clinical presentation, treatment and outcome in 31 dogs with presumed primary colorectal lymphoma (2001-2013).
Desmas I; Burton JH; Post G; Kristal O; Gauthier M; Borrego JF; Di Bella A; Lara-Garcia A
Vet Comp Oncol; 2017 Jun; 15(2):504-517. PubMed ID: 27028211
[TBL] [Abstract][Full Text] [Related]
30. Thymidine kinase assay in canine lymphoma.
Elliott JW; Cripps P; Blackwood L
Vet Comp Oncol; 2013 Mar; 11(1):1-13. PubMed ID: 22236202
[TBL] [Abstract][Full Text] [Related]
31. Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases.
Coupland SE; Krause L; Delecluse HJ; Anagnostopoulos I; Foss HD; Hummel M; Bornfeld N; Lee WR; Stein H
Ophthalmology; 1998 Aug; 105(8):1430-41. PubMed ID: 9709754
[TBL] [Abstract][Full Text] [Related]
32. Angiogenic markers in canine lymphoma tissues do not predict survival times in chemotherapy treated dogs.
Wolfesberger B; Tonar Z; Fuchs-Baumgartinger A; Walter I; Skalicky M; Witter K; Thalhammer JG; Pagitz M; Kleiter M
Res Vet Sci; 2012 Jun; 92(3):444-50. PubMed ID: 21596405
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of a 15-week CHOP protocol for the treatment of canine multicentric lymphoma.
Burton JH; Garrett-Mayer E; Thamm DH
Vet Comp Oncol; 2013 Dec; 11(4):306-15. PubMed ID: 22548975
[TBL] [Abstract][Full Text] [Related]
34. Determination of MDR1 gene expression for prediction of chemotherapy tolerance and treatment outcome in dogs with lymphoma.
Gramer I; Kessler M; Geyer J
Vet Comp Oncol; 2015 Dec; 13(4):363-72. PubMed ID: 23834200
[TBL] [Abstract][Full Text] [Related]
35. Outcome and toxicity associated with a dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 cases.
Sorenmo K; Overley B; Krick E; Ferrara T; LaBlanc A; Shofer F
Vet Comp Oncol; 2010 Sep; 8(3):196-208. PubMed ID: 20691027
[TBL] [Abstract][Full Text] [Related]
36. Histopathologic classification of 171 cases of canine and feline non-Hodgkin lymphoma according to the WHO.
Vezzali E; Parodi AL; Marcato PS; Bettini G
Vet Comp Oncol; 2010 Mar; 8(1):38-49. PubMed ID: 20230580
[TBL] [Abstract][Full Text] [Related]
37. OUTCOME OF DOGS WITH INTRANASAL LYMPHOMA TREATED WITH VARIOUS RADIATION AND CHEMOTHERAPY PROTOCOLS: 24 CASES.
George R; Smith A; Schleis S; Brawner W; Almond G; Kent M; Wypij J; Borrego J; Moore A; Keyerleber M; Kraiza S
Vet Radiol Ultrasound; 2016 May; 57(3):306-12. PubMed ID: 26763938
[TBL] [Abstract][Full Text] [Related]
38. Assessment of anemia as an independent predictor of response to chemotherapy and survival in dogs with lymphoma: 96 cases (1993-2006).
Abbo AH; Lucroy MD
J Am Vet Med Assoc; 2007 Dec; 231(12):1836-42. PubMed ID: 18081522
[TBL] [Abstract][Full Text] [Related]
39. The expression ratio of miR-17-5p and miR-155 correlates with grading in canine splenic lymphoma.
Albonico F; Mortarino M; Avallone G; Gioia G; Comazzi S; Roccabianca P
Vet Immunol Immunopathol; 2013 Sep; 155(1-2):117-23. PubMed ID: 23871213
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical expression of E-cadherin does not distinguish canine cutaneous histiocytoma from other canine round cell tumors.
Ramos-Vara JA; Miller MA
Vet Pathol; 2011 May; 48(3):758-63. PubMed ID: 21285383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
